A phase I study of recombinant human leukemia inhibitory factor in patients with advanced cancer.
Gunawardana DH, Basser RL, Davis ID, Cebon J, Mitchell P, Underhill C, Kilpatrick TJ, Reardon K, Green MD, Bardy P, Amor P, Crump D, Ng S, Nation RL, Begley CG.
Gunawardana DH, et al.
Clin Cancer Res. 2003 Jun;9(6):2056-65.
Clin Cancer Res. 2003.
PMID: 12796368
Clinical Trial.